Article info

Download PDFPDF
Letter
Using dual checkpoint blockade to treat fibrolamellar hepatocellular carcinoma

Authors

  1. Correspondence to Dr Enrico N De Toni, Department of Internal Medicine II, University of Munich, Munich 81377, Germany; enrico.detoni{at}med.uni-muenchen.de
View Full Text

Citation

De Toni EN, Roessler D
Using dual checkpoint blockade to treat fibrolamellar hepatocellular carcinoma

Publication history

  • Received January 4, 2020
  • Revised January 16, 2020
  • Accepted February 1, 2020
  • First published February 12, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.